Control glucémico y daño oxidativo a biomoléculas en diabéticos tipo 2
Céspedes Miranda, Ela María; Riverón Forment, Gretel; Alonso Rodríguez, Celia; Cabrera Pérez-Sanz, Elsa.
Rev. cuba. endocrinol
; 25(2): 46-56, Mayo.-ago. 2014.
Artículo en Español | LILACS, CUMED | ID: lil-727590
Documentos relacionados
Control glucémico y daño oxidativo a biomoléculas en diabéticos tipo 2
Evaluation of the Effectiveness of In-Hospital Exercise Rehabilitation in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus Combined with Sarcopenia Effect of Lifestyle Management on Disease Status in Patients with Type 2 Diabetes Mellitus.
Dynamic circadian fluctuations of glycemia in patients with type 2 diabetes mellitus.
Impact of total intravenous anesthesia and total inhalation anesthesia as the anesthesia maintenance approaches on blood glucose level and postoperative complications in patients with type 2 diabetes mellitus: a double-blind, randomized controlled trial.
Inadequate diabetes knowledge is associated with poor glycemia control in patients with type 2 diabetes.
Clinical characteristics and genetic analysis of a child with specific type of diabetes mellitus caused by missense mutation of <i>GATA6</i> gene.
Left ventricular systolic dyssynchrony: a novel imaging marker for early assessment of myocardial damage in Chinese type 2 diabetes mellitus patients with normal left ventricular ejection fraction and normal myocardial perfusion.
Relationship between key continuous glucose monitoring-derived metrics and specific cognitive domains in patients with type 2 diabetes mellitus.
Patients With Type 2 Diabetes: Anesthetic Management in the Ambulatory Setting. Part 1: Pathophysiology and Associated Disease States.
Lactobacillus GG is associated with mucin genes expressions in type 2 diabetes mellitus: a randomized, placebo-controlled trial.